A mathematical model analyzing the expression hierarchy of three validated glioma antigens (HER2, IL13Rα2, and EphA2) predicted an increased likelihood of tumor elimination when any two of these three antigens are targeted (59). The gene discussed is IL13RA2; the disease is central nervous system cancer.